4//SEC Filing
Matthews Judith M. 4
Accession 0001209191-23-022423
CIK 0001659323other
Filed
Apr 2, 8:00 PM ET
Accepted
Apr 3, 8:00 PM ET
Size
5.7 KB
Accession
0001209191-23-022423
Insider Transaction Report
Form 4
Matthews Judith M.
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-03-31+100,000→ 100,000 totalExercise: $1.00Exp: 2033-03-30→ Ordinary Shares (100,000 underlying)
Footnotes (1)
- [F1]The shares underlying this option shall vest at a rate of 33.3% of the total number of shares on the one-year anniversary of March 31, 2023 and the remaining 66.7% will vest in equal monthly installments thereafter until March 31, 2026, subject to the Reporting Person providing continuous service to the Issuer on each relevant vesting date.
Documents
Issuer
Iterum Therapeutics plc
CIK 0001659323
Entity typeother
Related Parties
1- filerCIK 0001734033
Filing Metadata
- Form type
- 4
- Filed
- Apr 2, 8:00 PM ET
- Accepted
- Apr 3, 8:00 PM ET
- Size
- 5.7 KB